New Nordic Healthbrands AB (publ)
Symbol: NNH.ST
STO
19.6
SEKDzisiejsza cena rynkowa
-12.6719
Wskaźnik P/E
0.0178
Wskaźnik PEG
121.43M
Kapitalizacja MRK
- 0.00%
Rentowność DIV
New Nordic Healthbrands AB (publ) (NNH-ST) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 53.85 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 433.07 | 101.9 | 116.5 | 97 | ||||||||||||||||
balance-sheet.row.inventory | 408.14 | 105.1 | 110.2 | 116.5 | ||||||||||||||||
balance-sheet.row.other-current-assets | 54.39 | 9.1 | 0 | 2.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 949.46 | 230 | 237.3 | 228.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 16.37 | 4.4 | 3.2 | 2.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 11.6 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 11.6 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0.92 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.tax-assets | 10.23 | 10.2 | 7 | 4.2 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 33.43 | 3.1 | -7 | 0 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 72.55 | 19.1 | 14.3 | 10.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1022 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.account-payables | 324.31 | 86.4 | 66.5 | 66 | ||||||||||||||||
balance-sheet.row.short-term-debt | 135.72 | 26.6 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.tax-payables | 10.27 | 2 | 1.7 | 3.6 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 8.22 | 2.2 | 1.6 | 0 | ||||||||||||||||
Deferred Revenue Non Current | -0.27 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.94 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 66.61 | 25.3 | 22.6 | 7.6 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 9.16 | 2.8 | 1.6 | 3.4 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-liab | 583.3 | 143 | 139.1 | 118 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 24.78 | 6.2 | 6.2 | 6.2 | ||||||||||||||||
balance-sheet.row.retained-earnings | 300.07 | 96.8 | 106.4 | 114.1 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 413.92 | 99.8 | 106.4 | 0.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -300.07 | -96.8 | -106.4 | -0.5 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 438.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1022 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 438.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1022 | - | - | - | ||||||||||||||||
Total Investments | 9.57 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.total-debt | 143.94 | 28.8 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.net-debt | 90.09 | 15 | 37.6 | 12.5 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -8.61 | -6.2 | -4.7 | 28.5 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2.03 | 1.2 | 1.6 | 0.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 14.87 | 31.7 | -3.4 | -31.1 | ||||||||||||||||
cash-flows.row.account-receivables | -3.85 | 2.8 | -10.4 | -4.6 | ||||||||||||||||
cash-flows.row.inventory | -12.04 | 4.9 | 6.3 | -35.8 | ||||||||||||||||
cash-flows.row.account-payables | 30.77 | 24 | 0.8 | 9.3 | ||||||||||||||||
cash-flows.row.other-working-capital | 0.66 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -1.29 | 1.3 | -9 | -6.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 5.48 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -3.16 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.11 | -0.3 | 0 | -0.3 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -3.05 | -3.4 | -2.6 | -3 | ||||||||||||||||
cash-flows.row.debt-repayment | -28.42 | -21.2 | -24.3 | -22.9 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -7.7 | -9.3 | ||||||||||||||||
cash-flows.row.other-financing-activites | -7.01 | 0 | 48.7 | 44.2 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.96 | -21.2 | 16.6 | 12.1 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.14 | -0.3 | 0.3 | 0.3 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -1.68 | 3.1 | -1.2 | 1.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 53.85 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 55.53 | 10.7 | 11.9 | 10.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 5.48 | 28 | -15.5 | -7.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -3.16 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 2.31 | 25 | -18.4 | -10.6 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 537.81 | 533.8 | 487.5 | 514.8 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 370.92 | 536.3 | 169 | 164.8 | ||||||||||||||||
income-statement-row.row.gross-profit | 166.89 | -2.5 | 318.5 | 350 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0.67 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 139.45 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 360.46 | 0.7 | 323.2 | 321.5 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 546.99 | 537 | 492.3 | 486.3 | ||||||||||||||||
income-statement-row.row.interest-income | 0.72 | 0.1 | 0 | 0 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.61 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -2.07 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -2.07 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.61 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 2.03 | 1.2 | 2.8 | 0.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -7.15 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -9.19 | -3.2 | -4.7 | 28.5 | ||||||||||||||||
income-statement-row.row.income-before-tax | -11.26 | -5.9 | -5.2 | 28 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -1.09 | 0.3 | -2.3 | 6.7 | ||||||||||||||||
income-statement-row.row.net-income | -10.17 | -6.2 | -2.8 | 21.3 |
Często zadawane pytania
Ile wynosi New Nordic Healthbrands AB (publ) (NNH.ST) aktywów ogółem?
New Nordic Healthbrands AB (publ) (NNH.ST) całkowite aktywa to 249060000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 272769000.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.310.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.373.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to -0.019.
Jaki jest całkowity przychód firmy?
Całkowity przychód to -0.017.
Co to jest New Nordic Healthbrands AB (publ) (NNH.ST) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -6194000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 28824000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 672000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 9865000.000.